Adaptive Biotechnologies Corp (ADPT) — Cash Flow Reinvestment Rate

Latest as of March 2019: 0.81x

Adaptive Biotechnologies Corp (ADPT) has a Cash Flow Reinvestment Rate of 0.81x as of March 2019, reinvesting $226.01 Million (capex $3.83 Million plus investments $-222.18 Million) from operating cash flow of $278.30 Million. Check Adaptive Biotechnologies Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.81x
(Capex + Investments) / Operating CF

Total Reinvested

$226.01 Million
Capex + Investments

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Adaptive Biotechnologies Corp Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Adaptive Biotechnologies Corp across 1 annual periods. Explore Adaptive Biotechnologies Corp (ADPT) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Adaptive Biotechnologies Corp (2019–2019)

Year-by-year capital reinvestment analysis for Adaptive Biotechnologies Corp. For live market cap and broader valuation context, see ADPT market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 2.35x $481.70 Million $205.40 Million $11.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow